Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - November 16, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that today it will commence trading on the Canadian Securities Exchange (the "CSE") under its new name and trading symbol. In connection with the name change, the Company has new CUSIP and ISIN numbers - 53946V107 and CA53946V1076 respectively. The Company is pleased to announce this milestone along with the launch of its...
2020-11-16 8:30 AM EST
GreenStar Biosciences Announces Name Change
Vancouver, British Columbia--(Newsfile Corp. - November 11, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") announces today it will be seeking approval of the Canadian Securities Exchange (the "CSE") to change its name from GreenStar Biosciences Corp. to Lobe Sciences Ltd. and change its CSE ticker symbol to "LOBE" (the "Name and Symbol Change"). There is no change of business associated with, or being effected with respect to, the Name and...
2020-11-11 5:30 PM EST
GreenStar Biosciences Announces Stock Option Issuance
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") announces it has granted stock options to acquire a total of 1,400,000 common shares of the Company to various directors, officers, and consultants of the Company pursuant to its Stock Option Plan. The options are exercisable at a price of $0.10 per share and expire three years from the date of grant. The options are subject to vesting...
2020-10-28 6:00 PM EDT
GreenStar Biosciences Announces Launch of Science Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - October 7, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce the formation and launch of its science advisory board (the "Science Advisory Board") and the appointment of its first distinguished board member, Dr. Mark Geyer, Professor Emeritus at University of California San Diego, who is a recognized pioneer in the psychedelics industry.The Science Advisory Board will serve as...
2020-10-07 8:00 AM EDT
GreenStar Biosciences Announces Closing of Private Placement
Vancouver, British Columbia--(Newsfile Corp. - October 5, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has completed its second and final closing of its previously announced non-brokered private placement of units (the "Units") (the "Offering") for gross proceeds of $866,498.72 (the "Second Tranche Closing"). The Second Tranche Closing consisted of the issuance of an aggregate of 10,831,234 Units at a price of...
2020-10-05 8:00 AM EDT
GreenStar Biosciences Announces First Closing of Private Placement
Vancouver, British Columbia--(Newsfile Corp. - September 21, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has completed a first closing of its previously announced non-brokered private placement of units (the "Units") of up to Cdn$4,000,000 (the "Offering") for gross proceeds of $831,748.16 (the "First Tranche Closing"). The First Tranche Closing consisted of the issuance of an aggregate of 10,396,852 Units at...
2020-09-21 8:00 AM EDT
GreenStar Biosciences Announces New Provisional Patent Application
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce that its wholly-owned subsidiary, Eleusian Biosciences Corporation ("Eleusian") has added another provisional patent application to the overall existing intellectual property ("IP") portfolio of the Company. This application further expands the portfolio of proprietary psychedelic therapeutics and devices available...
2020-09-14 8:00 AM EDT
GreenStar Biosciences Announces Private Placement and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 17, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF), ("GreenStar" or the "Company"), is pleased to announce that it has engaged Australian boutique brokerage firm, Peak Asset Management ("Peak") to act as non-exclusive financial adviser and raise up to Cdn$4,000,000 (the "Offering") through a private placement of up to 50,000,000 units (the "Units") at a price of $0.08 per Unit. Each Unit will consist of one common share...
2020-08-17 9:11 AM EDT
GreenStar Biosciences Announces Filing of Fourth Provisional Patent Application
Vancouver, British Columbia--(Newsfile Corp. - August 5, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce that its wholly-owned subsidiary, Eleusian Biosciences Corporation ("Eleusian"), has filed a new provisional patent application, adding to the overall existing intellectual property portfolio of the Company. This application further expands the portfolio of proprietary psychedelic therapeutics available to GreenStar...
2020-08-05 8:30 AM EDT
GreenStar Biosciences' Partner Cowlitz Reports Revenues for Q1 2020
Vancouver, British Columbia--(Newsfile Corp. - July 29, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated over US$6.58 million in gross sales revenues for the three months ended March 31, 2020, resulting in a 24% increase compared to US$ 5.3 million for the first 3 months in 2019, according to data from www.502data.com. GreenStar...
2020-07-29 8:30 AM EDT
GreenStar Biosciences Completes Acquisition of 100% of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer
Vancouver, British Columbia--(Newsfile Corp. - July 27, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press release dated July 21, 2020, that it has completed the acquisition of 100% of Toronto, Ontario-based Eleusian Biosciences Corp. ("Eleusian") (the "Transaction") through the issuance of common shares of GreenStar. In addition, the Company is pleased to announce the appointment of Mr. Jonathan...
2020-07-27 9:00 AM EDT
GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences
Vancouver, British Columbia--(Newsfile Corp. - July 23, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce that Eleusian Biosciences Corporation ("Eleusian") has added to its existing intellectual property portfolio by filing a third provisional patent application. This application further expands the portfolio of proprietary psychedelic therapeutics available to GreenStar and strengthens the intellectual property ("IP")...
2020-07-23 7:59 AM EDT
GreenStar Biosciences Announces Closing of Private Placement and Debt Settlement
Vancouver, British Columbia--(Newsfile Corp. - July 23, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has closed a non-brokered private placement of common shares for gross proceeds of $585,000 (the "Offering"). The Offering consisted of the issuance of an aggregate of 11,700,000 common shares in the capital of the Company (the "Shares") at a price of $0.05 per Share. The Company also announces that it has...
2020-07-23 7:50 AM EDT
GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press release dated June 16, 2020, that it has signed a definitive binding share exchange agreement dated July 20, 2020 (the "Agreement") to acquire 100% of Toronto, Ontario-based Eleusian Biosciences Corp. ("Eleusian") (the "Transaction") through the issuance of common shares of GreenStar. This...
2020-07-21 9:00 AM EDT
GreenStar Biosciences Announces Non-Brokered Private Placement and Debt Settlement
Vancouver, British Columbia--(Newsfile Corp. - July 20, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it will proceed with a non-brokered private placement of common shares to raise gross proceeds of up to $585,000 (the "Offering"). The Offering will consist of the issuance of an aggregate of up to 11,700,000 common shares in the capital of the Company (the "Shares") at a price of $0.05 per Share....
2020-07-20 9:00 AM EDT
GreenStar Biosciences: Jonathan Gilbert, Eleusian Biosciences CEO, to Speak at Peak Asset Management's Psychedelic Investment Webinar
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2020) - Eleusian CEO, Jonathan Gilbert, will be speaking at the Peak Asset Management's Psychedelic Investment Webinar this Thursday, June 18th at 7:30PST. The Webinar is titled: "Psychedelic Stocks On The Charge in North America Creates Opportunities for Global Investors" and is being hosted by Peter Hunt, Co-founder and Chair of Mind Medicine Australia, a registered charity seeking to establish safe and effective psychedelic-assisted...
2020-06-17 1:53 PM EDT
Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has signed a non-binding letter of intent dated June 12, 2020 (the "Agreement") to acquire 100% of Eleusian Biosciences Corp. ("Eleusian") (the "Transaction") through the issuance of common shares of GreenStar.Transaction Highlights:Brings seasoned pharmaceutical leader and executive to GreenStar: Maghsoud...
2020-06-16 9:27 AM EDT
GreenStar Biosciences Announces Stock Option Issuance and Cancellation of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), announces it has granted stock options to acquire a total of 200,000 common shares of the Company to a director of the Company. The options are exercisable at a price of $0.14 per share and expire three years from the date of grant. The options are subject to various vesting provisions where 150,000 of the options granted vest immediately on the...
2020-05-25 6:30 AM EDT
GreenStar Biosciences Announces Resignation of Independent Board Member
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), announced today the resignation of Faizaan Lalani from its Board of Directors for personal reasons.The Company wishes to thank Faizaan for his many years of service and contributions during his tenure as Director of the Company. The Company will immediately begin a search for a new independent board member to replace Faizaan.About GreenStarGreenStar is a...
2020-04-17 5:00 PM EDT
GreenStar Biosciences' Cowlitz Reports Record Breaking Revenues of US$19.5 M for 2019
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated over US$19.5 million in gross sales revenues for 2019."We are very pleased with the rate at which Cowlitz is growing. 2019 revenues represent a 33% increase over 2018," said Rahim Rajwani, Chair of the Strategic Advisory Board to GreenStar. Newly...
2020-03-02 8:00 AM EST